Organon & Co. — Director's Dealing 2022

Mar 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2022-02-28

Reporting Person: Fiedler Susanne (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-28	Common Stock	M	8718	—	Acquired	11638	Direct
2022-02-28	Common Stock	F	4098	$37.57	Disposed	7540	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-28	Restricted Stock Units	$	M	8718	Disposed	2021-12-31	Common Stock (8718)	Direct

Footnotes

F1: Each restricted stock unit converts into one share of Organon & Co. common stock.

F2: As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022.

F3: The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.